The global vertebral compression fractures devices market is set to hit nearly $1.19 million by 2022, based on an Allied Market Research report, according to medGadget.
Here are nine observations:
1. In 2015, the market was valued at $748 million.
2. The VCF devices market will likely grow at a compound annual growth rate of 5.7 percent through 2022.
3. The adoption of minimally invasive spine surgery as well as prevalence of osteoporosis and arthritis will spur market growth.
4. The post-surgical complication risk as well as unfavorable regulatory approval processes may hinder market growth.
5. The balloon kyphoplasty devices segment will continue to lead the market, due to the procedure's ability to reduce back pain and restore vertebral body height. This segment captured almost four-fifths of the global market in 2015.
6. The vertebroplasty devices segment will grow at a 6.1 percent CAGR.
7. In 2015, North America led the pack, accounting for two-thirds of the global market share.
8. The Asia-Pacific region will grow at a 6.7 percent CAGR.
9. Key market players include Alphatec Holdings, Benvenue Medical, DePuy Synthes, Globus Medical, Medtronic, Orthovita, Osseon, Stryker Corp., VEXIM and Zimmer Biomet.